Endocrine Disorders in the Pediatric Client
Download
Report
Transcript Endocrine Disorders in the Pediatric Client
Endocrine Disorders in
the Pediatric Client
Susan Beggs, MSN, CPN
Understanding the endocrine
system in children
Puberty brings many changes
↑GH released
↑ production of LH and FSH in girls
Development of sexual characteristics
Feedback mechanism in place
Collecting data during an
endocrine assessment
Percentiles on weight and height
Distinguishing facial features, abd. fat
Onset of puberty
Routine NB screening
Blood glucose levels
Detection of chromosomal disorders
Pancreatic dysfunctions
Etiology
Preclinical stage
Manifestations
Diagnosis
Therapy for diabetes in
children
Diagnosis:
Under 18?
Type I diabetes
Clinical therapy combines:
insulin
nutrition
exercise regimen
psychosocial support
Insulin therapy
Insulin review
Rapid (Lispro/Humalog)
Short acting (regular)
Intermediate acting (NPH, Lente)
Long acting (Lantus/Ultralente)
Basal-bolus therapy
ADA recommendations for children
Basal insulin administered 1-2x day; bolus of
rapid acting with each meal and snack
Method of this therapy:
Lower glucose levels
Stabilize glucose levels
Eliminate ketones
Insulin dose adjusted to BS readings 4x day
Basal bolus, cont.
BS monitored 4-8x day; 1x a week at
midnight and 3AM
Therapy can be achieved with 3+ insulin
injections a day or by pump
There must be consistent carb counts
Routine exercise
Factors which may affect
insulin dosage in children
Stress
Infection
Illness
Growth spurts (such as puberty)
Meal coverage for finicky toddlers
Adolescents concerned about weight
gain not wanting to eat AM snack
External insulin infusion
pump in children
Advantages
Delivers continuous infusion
Maintain better control
# of injection sites
hypo/hyper episodes
More flexible lifestyle
Eat with more flexibility
Improves growth in child
Disadvantages
Requires motivation
Requires willingness to be
connected to device
Change sites every 2-4 days
More time/energy to monitor
BS
Syringe, cath changes every
2-3 days
Infection may occur at site
Wt gain common when BS is
controlled
Insulin therapy, cont.
Monitored every 3 months by hemoglobin
A1c
Represents amt of glucose attached to
hemoglb over period of time
Roughly 120 days
Good predictor of levels over 6-8 wks
Nursing Management at
the time of diagnosis
Child is admitted to hospital
Nsg assessments directed toward:
Hydration
LOC
Hourly monitoring of BS
Dietary and caloric intake
Ability of family to manage
“Sick Day guidelines”
Days that child is ill
Attention to glycemic control
BS levels more often than routine
DO NOT SKIP INSULIN!
Factors key to preventing DKA
Home Teaching
Incorporate into the family lifestyle
“Honeymoon phase”
Community resources
Recognizing the cognitive
levels at time of teaching
Diabetic Ketoacidosis
Review of patho
Causes
Criteria for diagnosis of DKA
BS levels> 300
Serum ketones
↓ bicarbonates
Acidosis (pH <7.3)
Treatment for DKA
Fluids (boluses)
Wean off IV insulin when clinical stable
Oral feedings introduced when alert
Prevention of future episodes
Type II diabetes in
children
There is insulin resistance
Fatty tissue produces hormone
Hormone desensitized to insulin
Can result in hyperinsulinism
Signs and symptoms
Acanthosis nigricans
Inborn errors of
metabolism
Phenylketonuria
Galactosemia
Defects in Fatty Acid Oxidation
Maple syrup urine disease
Phenylketonuria (PKU)
Autosomal recessive
Liver deficiency
Treatment/education
Counseling for future pregnancies
Galactosemia
Carbohydrate metabolic dysfuntion
Autosomal recessive
Liver enzyme deficiency
Implications/symptoms
Treatment/management
Defects in fatty acid
oxidation
Defects result in fatty acid oxidation
Most common of inborn errors
Most common presentation
Diagnosis/treatment
Maple syrup urine disease
(MSUD)
Disorder of amino acid metabolism
Diagnosis made by UA
Treatment/management
Nursing measures for
metabolic disorders
Genetic counseling
Dietary teaching.compliance
Mixing special preparations
Mainly supportive